Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
03.02. | 4D Molecular Therapeutics, Inc.: 4DMT Presents Positive Interim Data from Randomized Phase 2 PRISM Clinical Trial of Intravitreal 4D-150 Demonstrating Favorable Tolerability & Clinical Activity in Wet AMD | 198 | GlobeNewswire (Europe) | 51 wet AMD patients with severe disease activity (mean of 442 µm central subfield thickness & presence of retinal fluid) and high treatment burden (mean of 10 anti-VEGF injections in preceding 12... ► Artikel lesen | |
03.02. | EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Announces Two Presentations of Topline Data with Additional Subgroup Analyses from the Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Treatment of Wet Age-Related Macular Degeneration | 234 | GlobeNewswire (Europe) | Subgroup analyses underscore favorable clinical profile and durability of EYP-1901Presentations highlight previously reported positive Phase 2 DAVIO 2 topline results showing all primary and secondary... ► Artikel lesen | |
03.02. | WUXI BOYU PLASTIC MACHINERY CO., LTD.: Wuxi Boyu Plastic Machinery Showcases the Latest SPC Flooring Innovations at DOMOTEX 2024 | 790 | GlobeNewswire (Europe) | WUXI, China, Feb. 03, 2024 (GLOBE NEWSWIRE) -- Boyu, a renowned brand in the flooring industry, took center stage at DOMOTEX 2024, underlining its position as a leader in SPC flooring manufacturing.... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 464 |
EVOTEC | 421 |
TUI | 319 |
NVIDIA | 264 |
BAYER | 241 |
DEUTSCHE BANK | 234 |
PLUG POWER | 221 |
NEL | 217 |
RHEINMETALL | 195 |
SIEMENS ENERGY | 178 |
COMMERZBANK | 170 |
TESLA | 152 |
BARRICK GOLD | 148 |
BASF | 143 |
RWE | 143 |
VOLKSWAGEN | 142 |
BYD | 140 |
DEUTSCHE LUFTHANSA | 135 |
DEUTSCHE TELEKOM | 128 |
ALLIANZ | 127 |
MERCEDES-BENZ | 121 |
RENK GROUP | 116 |
ALIBABA | 111 |
REDCARE PHARMACY | 110 |
E.ON | 109 |